Shares of Ocugen Inc. /zigman2/quotes/208160861/composite OCGN +5.72% rallied 1.88% to $8.69 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.08% rising 0.06% to 4,649.27 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.56% falling 0.44% to 35,921.23. The stock's rise snapped a three-day losing streak. Ocugen Inc. closed $10.08 below its 52-week high ($18.77), which the company reached on February 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Adverum Biotechnologies Inc. /zigman2/quotes/210484271/composite ADVM +3.13% fell 1.76% to $2.23, Ocular Therapeutix Inc. /zigman2/quotes/207607068/composite OCUL +0.65% rose 3.87% to $7.51, and Kodiak Sciences Inc. /zigman2/quotes/207655028/composite KOD +3.68% rose 0.35% to $112.12. Trading volume (29.1 M) remained 7.9 million below its 50-day average volume of 37.1 M.